Principal Investigators

    Leblanc, Andréa C


    Jewish General Hospital (Montreal)

    Contact information of lead PI



    Title of project or programme

    Role of caspases in human neuronal cell death and in Alzheimer's disease.

    Source of funding information


    Total sum awarded (Euro)

    € 507,841

    Start date of award


    Total duration of award in years


    The project/programme is most relevant to:

    Alzheimer's disease & other dementias


    Research Abstract

    Current therapies against Alzheimer disease are very limited. One possible reason for failure to achieve efficient therapies against Alzheimer disease is that we do not have a thorough understanding of the earliest degenerative events that occur in the brain to lead to Alzheimer disease. The research of my team is dedicated at identifying the earliest degenerative processes that occur in aging brains. We have identified that Caspase-6, an enzyme that causes neurodegeneration, is activated in some aged individuals but not in younger individuals. The Caspase-6 is activated in the area of the brain first affected by Alzheimer disease. Caspase-6 is also abundantly active in brains of Alzheimer disease patients at all stages of the disease and is present in all areas that are affected by Alzheimer disease. In this proposal, we will try to further understand how Caspase-6 is activated in neurons, attempt to develop a mouse model with Alzheimer disease by expressing Caspase-6 in the brain of mice, and assess the effects of Caspase-6 on neuronal function. The results of these experiments could indicate that Caspase-6 is an important therapeutic target against Alzheimer disease.

    Lay Summary

    Further information available at:

Types: Investments > €500k
Member States: Canada
Diseases: Alzheimer's disease & other dementias
Years: 2016
Database Categories: N/A
Database Tags: N/A

Export as PDF